Characterization of Single-Nucleotide Polymorphisms in the Tumor Necrosis Factor α Promoter Region and in Lymphotoxin α in Squamous Intraepithelial Lesions, Precursors of Cervical Cancer
- PMID: 22190997
- PMCID: PMC3243656
- DOI: 10.1593/tlo.11226
Characterization of Single-Nucleotide Polymorphisms in the Tumor Necrosis Factor α Promoter Region and in Lymphotoxin α in Squamous Intraepithelial Lesions, Precursors of Cervical Cancer
Abstract
Development of cervical cancer is a long process of abnormal cancerous cell growth in the cervix and is primarily the result of infection with specific high-risk types of human papillomavirus (HPV). The cytokines tumor necrosis factor α (TNFα) and lymphotoxin α (LTA) have an important role in all stages of cervical cancer and have the ability to induce the regression or promote the development of human tumors. Biologically important single-nucleotide polymorphisms (SNPs) occur within the TNFα and LTA genes. Therefore, the purpose of this study was to investigate the SNPs in the TNFα promoter region (-163, -238, -244, -308, -376, -857, -863, and -1031) and in the first intron of LTA (+252) in women with precursor lesions of cervical cancer. Overall, we studied 396 women from Mexico City. A total of 191 patients with HPV infection and precursor cervical lesions were subdivided in two groups: those with low-grade squamous intraepithelial lesions (n = 132) and those with high-grade squamous intraepithelial lesions (n = 59). Women (n = 205) negative for HPV and without cervical lesions were also included in the study. DNA was extracted from peripheral white blood cells and from cervical samples, and detection of biallelic polymorphisms of TNFα and LTA was performed using the polymerase chain reaction-sequence-specific oligonucleotide probe and restriction fragment length polymorphism techniques, respectively. We demonstrated that risk is associated with the genotype G/A (odds ratio = 2.48) and that protection is associated with the genotype G/G of SNP TNFα -376 (odds ratio = 0.37).
Figures
Similar articles
-
Significant association between IL10-1082/-819 and TNF-308 haplotypes and the susceptibility to cervical carcinogenesis in women infected by Human papillomavirus.Cytokine. 2019 Jan;113:99-104. doi: 10.1016/j.cyto.2018.06.014. Epub 2018 Jun 20. Cytokine. 2019. PMID: 29935877
-
Distribution of human papillomavirus genotypes in Paraguayan women according to the severity of the cervical lesion.J Med Virol. 2011 Aug;83(8):1351-7. doi: 10.1002/jmv.22112. Epub 2011 May 26. J Med Virol. 2011. PMID: 21618554
-
Polymorphisms in the TGFB1 signal peptide influence human papillomavirus infection and development of cervical lesions.Med Microbiol Immunol. 2019 Feb;208(1):49-58. doi: 10.1007/s00430-018-0557-y. Epub 2018 Aug 30. Med Microbiol Immunol. 2019. PMID: 30167873
-
Synergic effect of oral contraceptives, GSTP1 polymorphisms, and high-risk HPV infection in development of cervical lesions.Genet Mol Res. 2017 Aug 17;16(3). doi: 10.4238/gmr16039742. Genet Mol Res. 2017. PMID: 28829907
-
Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.J Med Virol. 2014 Oct;86(10):1772-9. doi: 10.1002/jmv.23997. Epub 2014 Jun 30. J Med Virol. 2014. PMID: 24978445
Cited by
-
The Correlation Between TNF-α Promoter Gene Polymorphism and Genetic Susceptibility to Cervical Cancer.Technol Cancer Res Treat. 2018 Jan 1;17:1533033818782793. doi: 10.1177/1533033818782793. Technol Cancer Res Treat. 2018. PMID: 29940817 Free PMC article.
-
Interactions between polymorphisms in the 3'untranslated region of the cyclin dependent kinase 6 gene and the human papillomavirus infection, and risk of cervical precancerous lesions.Biomed Rep. 2017 Jun;6(6):640-648. doi: 10.3892/br.2017.898. Epub 2017 May 3. Biomed Rep. 2017. PMID: 28584635 Free PMC article.
-
The Association of Serum TNF-α Levels and Blood Multi-Elements Modified by TNF-α Gene Polymorphisms in Metal Industrial Workers.Int J Environ Res Public Health. 2019 Oct 23;16(21):4079. doi: 10.3390/ijerph16214079. Int J Environ Res Public Health. 2019. PMID: 31652851 Free PMC article.
-
Promising candidate drug target genes for repurposing in cervical cancer: A bioinformatics-based approach.Narra J. 2024 Dec;4(3):e938. doi: 10.52225/narra.v4i3.938. Epub 2024 Dec 12. Narra J. 2024. PMID: 39816079 Free PMC article.
-
TNF-α -308 G/A as a risk marker of cervical cancer progression in the Polish population.Mol Diagn Ther. 2015 Feb;19(1):53-7. doi: 10.1007/s40291-015-0130-y. Mol Diagn Ther. 2015. PMID: 25614219
References
-
- Palacio-Mejia LS, Rangel-Gomez G, Hernández-Avila M, Lazcano-Ponce E. Cervical cancer, a disease of poverty: mortality differences between urban and rural area in Mexico. Salud Publica Mex. 2003;45:S315–S325. - PubMed
-
- Fernandez AM, Gonçalves GM, Duarte G, Cunha QF, Simoes TR, Danadi AE. HPV16, HPV18, and HIV infection may influence cervical cytokine intralesional levels. Virology. 2005;334:294–298. - PubMed
-
- zur Hausen H. Papillomaviruses and cancer. From Fbasic studies to clinical application. Nat Rev Cancer. 2002;2:342–350. - PubMed
LinkOut - more resources
Full Text Sources